会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Methods and kits for the diagnosis of sickle cell
    • 用于诊断镰状细胞的方法和试剂盒
    • US20080255766A1
    • 2008-10-16
    • US12068518
    • 2008-02-07
    • Michael SpainJames P. MapesRalph L. McDadeKenneth Pass
    • Michael SpainJames P. MapesRalph L. McDadeKenneth Pass
    • G01N33/53C12Q1/00
    • G01N33/6863G01N2333/52G01N2800/22
    • Provided are methods for the detection and diagnosis of sickle cell. The methods are based on the discovery that abnormal levels of selected analytes in sample fluid, typically blood samples, of patients who are at risk are supportive of a diagnosis of sickle cell. At least two new biomarkers for sickle cell are thus disclosed, Eotaxin and Monocyte Chemotactic Protein-1. Altogether the concentrations of eleven analytes provide a sensitive and selective picture of the patient's condition, namely, whether the patient is suffering from sickle cell. Other important biomarkers for sickle cell are described, including but not limited to IL-12p40, SHBG, MMP-9, Adiponectin, Haptoglobin, FGF basic, IgM, Growth Hormone, Factor VII. Kits containing reagents to assist in the analysis of fluid samples are also described.
    • 提供了镰状细胞的检测和诊断方法。 这些方法是基于以下发现:患有风险的患者的样本液体(通常为血液样本)中所选分析物的异常水平支持镰状细胞的诊断。 因此公开了至少两种镰状细胞的新生物标志物,即嗜酸细胞活化趋化因子和单核细胞趋化蛋白-1。 总共11种分析物的浓度提供了对患者状况的敏感和选择性图像,即患者是否患有镰状细胞。 描述了镰状细胞的其他重要生物标志物,包括但不限于IL-12p40,SHBG,MMP-9,脂连蛋白,海藻球蛋白,FGF碱性,IgM,生长激素,因子VII。 还描述了含有辅助分析流体样品的试剂的试剂盒。
    • 2. 发明申请
    • METHODS FOR RAPID DISEASE SCREENING
    • 快速筛查筛查方法
    • US20100197510A1
    • 2010-08-05
    • US12529840
    • 2008-03-07
    • Michael SpainCraig BensonJames P. MapesRalph L. McDade
    • Michael SpainCraig BensonJames P. MapesRalph L. McDade
    • C40B30/00
    • G01N33/6803
    • Methods are provided for screening for the necessity for further diagnosis of one or more diseases or conditions in a subject, which methods are based on the discovery that abnormal levels of selected analytes in a sample fluid from a subject can be correlated with specific diseases or conditions. Further provided are criteria, and methods for the determine thereof, for selected analytes with respect to selected diseases or conditions. Thus, a variety of diseases or conditions can be screened in a rapid, cost-effective composite assay. The methods are useful for screening of newborn humans for a variety of diseases and conditions, whereby additional diagnostic procedures need only be conducted for those diseases or conditions indicated by the methods of the invention.
    • 提供了筛选用于进一步诊断受试者中一种或多种疾病或病症的必要性的方法,该方法基于以下发现:来自受试者的样品液体中的选定分析物的异常水平可与特定疾病或病症相关 。 关于所选择的疾病或病症,进一步提供了用于确定所选分析物的标准和方法。 因此,可以以快速,成本有效的复合测定法筛选各种疾病或病症。 该方法可用于筛选各种疾病和病症的新生儿,由此仅需对本发明方法所指出的那些疾病或病症进行额外的诊断程序。